Analysts have provided mixed reviews on Nevro Corp (NYSE:NVRO) with 1 somewhat bullish, 6 indifferent, and 1 somewhat bearish rating over the past three months. The average 12-month price target is $19.62, down from the previous $22.25. Recent actions include both lowered and raised price targets, with the highest at $23.00 and the lowest at $15.00. Nevro's financials show a revenue growth of 3.38% over 3 months, but it lags behind industry peers and has a net margin of -22.61%, ROE of -8.09%, ROA of -4.15%, and a high debt-to-equity ratio of 0.68.